...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >COMPARATIVE STUDY ON THE EFFICACY OF MOMETASONE AND FLUTICASONE NASAL SPRAYS FOR TREATMENT OF ALLERGIC RHINITIS
【24h】

COMPARATIVE STUDY ON THE EFFICACY OF MOMETASONE AND FLUTICASONE NASAL SPRAYS FOR TREATMENT OF ALLERGIC RHINITIS

机译:莫米松和氟替卡松鼻喷雾剂治疗变应性鼻炎的疗效比较研究

获取原文
           

摘要

Objective: Allergic rhinitis is the most prevalent of allergic diseases in the world. Nasal corticosteroids are the most applicable drugs for the treatment of allergic rhinitis. In this study, we compared the efficacy of fluticasone propionate (FP) and mometasone furoate (MF) nasal sprays in the treatment of allergic rhinitis based on total nasal symptom score (TNSS) questionnaire. Methods: For this study, 75 allergic rhinitis patients based on skin prick test and inclusion criteria were randomly assigned to two groups: FP and MF groups. FP group received 200 μg dose of FP nasal spray (1 sprayostril) daily and the MF group received 100 mg dose of MF nasal spray (1 sprayostril) daily for 8 w. The effects of the two agents were compared based on TNSS questionnaire in 0, 4 and 8 w after the beginning of the treatment. Results: Results showed that patients in both groups exhibited significant improvement in their TNSS (P Value0.05). Conclusion: In conclusion, FP and MF are significantly effective in relieving of allergic rhinitis symptoms. Even though, the difference between the two is not significant for 8 w therapy.
机译:目的:过敏性鼻炎是世界上最普遍的过敏性疾病。鼻皮质激素是治疗过敏性鼻炎最适用的药物。在这项研究中,我们根据总鼻症状评分(TNSS)问卷比较了丙酸氟替卡松(FP)和糠酸莫米松(MF)鼻腔喷雾剂治疗过敏性鼻炎的疗效。方法:本研究将75名基于皮肤点刺试验和纳入标准的变应性鼻炎患者随机分为两组:FP组和MF组。 FP组每天接受200μg剂量的FP鼻喷雾剂(1喷雾/鼻孔),MF组每天接受100 mg剂量的MF鼻喷雾剂(1喷雾/鼻孔),持续8 w。在开始治疗后的0、4和8 w,根据TNSS问卷比较了两种药物的效果。结果:结果表明,两组患者的TNSS均有显着改善(P值0.05)。结论:总之,FP和MF在缓解过敏性鼻炎症状方面具有显着效果。即使对于8 w疗法,两者之间的差异并不显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号